Sessile Serrated Lesion
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Huadong MedicineChina - Hangzhou
2 programsAcetic Acid-Indigo Carmine Chromocolonoscopy GroupN/A
Polyp Pretreatment DeviceN/A
Integrated BiosciencesCA - San Carlos
2 programsAcetic Acid-Indigo Carmine Chromocolonoscopy GroupN/A1 trial
Polyp Pretreatment DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2026
2027
2028
Integrated BiosciencesAcetic Acid-Indigo Carmine Chromocolonoscopy Group
Integrated BiosciencesPolyp Pretreatment Device
Clinical Trials (2)
Total enrollment: 3,845 patients across 2 trials
Impact of Acetic Acid-Indigo Carmine Chromocolonoscopy on Proximal Sessile Serrated Lesions
Start: Jun 2026Est. completion: Nov 20282,689 patients
N/ANot Yet Recruiting
Polyp Pretreatment Device for SSL Diagnosis
Start: Jun 2026Est. completion: May 20281,156 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.